OxTalks is Changing
During Michaelmas Term, OxTalks will be moving to a new platform (full details are available on the Staff Gateway).
For now, continue using the current page and event submission process (freeze period dates to be advised).
If you have any questions, please contact halo@digital.ox.ac.uk
Quell Therapeutics - Opportunities and Challenges in Biotech, 2024
Quell Therapeutics is a London, UK based, private biopharmaceutical company. Their vision is to be the leading engineered cell therapy company, bringing transformational and valued therapies addressing a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation.
Date:
18 January 2024, 12:00
Venue:
IMS-Tetsuya Nakamura Building, Roosevelt Dr, Headington OX3 7TY
Venue Details:
Ground Floor Seminar Room - followed by lunch and networking. Also available via Zoom.
Speaker:
Luke Devey (Vice President, Head of Translational Science, Immunology)
Organising department:
Medical Sciences Office
Organisers:
Sheena Lee (MSD Business Partnerships Office),
Dr Charlotte Bell (University of Oxford),
Medical Sciences Division Business Partnerships Office (University of Oxford)
Organiser contact email address:
sheena.lee@medsci.ox.ac.uk
Hosts:
Sheena Lee (MSD Business Partnerships Office),
Dr Charlotte Bell (University of Oxford)
Part of:
Industry Insight Seminar Series
Booking required?:
Required
Booking url:
https://forms.office.com/e/suZ1J5CiU1
Cost:
Free
Audience:
Public
Editor:
Sheena Lee
